News
Noma Therapy, a virtual ketamine-assisted therapy provider, has launched with $4.25 million in funding, Endpoints News ...
“Our team is pleased to report that SP-26 met all expectations in this preclinical study,” said Eric Weisblum, CEO of Silo Pharma. “We believe these results support the advancement of SP-26 as a ...
Deep sedation with remimazolam plus ketamine during atrial fibrillation ablation is linked to fewer clinically relevant ...
Inner Healing, a pioneering psychiatric practice specializing in innovative, evidence-based treatments such as Transcranial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results